Virtue VC

Virtue VC is a New York-based seed firm focused on digital health and healthcare IT, and the firm’s posture is straightforwardly early-stage and concentrated. It writes $250k-$1M checks at pre-seed and seed, sits inside the dense East Coast healthcare ecosystem, and runs a relatively narrow thesis rather than spreading itself across consumer tech adjacencies. Founders engaging the firm should expect a healthcare-first conversation rather than a generalist software pitch.

The declared sub-verticals are digital health and health IT software, with an AI lens layered across both. In practice that means interest in companies addressing clinical workflow automation, payer-provider technology, care navigation, value-based care enablement, and AI applications inside healthcare enterprises. The firm tends to be less drawn to consumer wellness with weak retention, hardware-heavy diagnostics, or therapeutics. The strongest fits are software companies whose customers are health systems, payers, life-sciences operators, or other healthcare enterprises, with a clear path from initial pilots to enterprise contracts.

Check sizes of $250k-$1M place Virtue inside the early-stage syndicate band rather than as a sole lead in larger rounds. The firm is comfortable as a co-lead on smaller seed deals and as a meaningful syndicate participant in larger rounds where another firm anchors the round. Geographically the focus is US healthcare with a concentration around New York and East Coast academic medicine, although the firm writes into companies based across the country when the thesis fits. Founders should be ready for questions about how their go-to-market strategy will land inside US payer and provider buying dynamics specifically.

The team is small and senior, with the kind of operator and investor backgrounds that translate into informed early-stage diligence rather than process-heavy fund machinery. Founders should expect direct conversations about the buyer, the workflow, the clinical evidence, and the pricing logic, with relatively little patience for marketing language that wraps an unclear thesis. The firm tends to be deliberate rather than high-volume, which means founders who get a yes are typically getting attention rather than just a check.

For founders, the practical read is that Virtue is a credible early-stage partner for digital health and healthcare IT software companies in the US, particularly those addressing real enterprise problems with software-defined solutions. It is not a fit for consumer-only wellness plays, for therapeutics, or for founders who want a generalist tech investor. The engagement style is hands-on at the seed stage, with real involvement in early hiring, go-to-market, and the move from pilot to first paying enterprise customer. Founders building enterprise healthcare software in the US who want a focused early-stage co-lead with East Coast healthcare relationships will find this firm a sensible call.